Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside.

× No keyword cloud information.

25 in total

1. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.

Authors: J Laliberté; V E Marquez; R L Momparler
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

2. Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells.

Authors: Hongmei Ruan; Songbo Qiu; Brian C Beard; Margaret E Black
Journal: Protein Eng Des Sel Date: 2016-05-08 Impact factor: 1.650

3. A rearrangement of the CDD gene at the 5' UTR produces two types of transcripts that contain a natural antisense region.

Authors: H Jung-Ha; Y Lee; D Kim; B H Song
Journal: Mol Biol Rep Date: 1998-11 Impact factor: 2.316

4. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.

Authors: W J Moriconi; M Slavik; S Taylor
Journal: Invest New Drugs Date: 1986 Impact factor: 3.850

5. SGI-110: DNA Methyltransferase Inhibitor Oncolytic.

Authors: E A Griffiths; G Choy; S Redkar; P Taverna; M Azab; A R Karpf
Journal: Drugs Future Date: 2013-08 Impact factor: 0.148

Review 6. Epigenetic Determinants of Cancer.

Authors: Stephen B Baylin; Peter A Jones
Journal: Cold Spring Harb Perspect Biol Date: 2016-09-01 Impact factor: 10.005

Review 7. Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.

Authors: Giuseppe Leone; Francesco D'Alò; Giuseppe Zardo; Maria Teresa Voso; Clara Nervi
Journal: Curr Med Chem Date: 2008 Impact factor: 4.530

8. Chemical decomposition of 5-aza-2'-deoxycytidine (Decitabine): kinetic analyses and identification of products by NMR, HPLC, and mass spectrometry.

Authors: Daniel K Rogstad; Jason L Herring; Jacob A Theruvathu; Artur Burdzy; Christopher C Perry; Jonathan W Neidigh; Lawrence C Sowers
Journal: Chem Res Toxicol Date: 2009-06 Impact factor: 3.739

9. Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI-110) in Hepatocellular Carcinoma.

Authors: Minmin Liu; Lian Zhang; Hongtao Li; Toshinori Hinoue; Wanding Zhou; Hitoshi Ohtani; Anthony El-Khoueiry; John Daniels; Casey O'Connell; Tanya B Dorff; Qianjin Lu; Daniel J Weisenberger; Gangning Liang
Journal: Hepatology Date: 2018-10 Impact factor: 17.425

10. Cytidine deaminase activity as a measure of acute inflammation in rheumatoid arthritis.

Authors: P W Thompson; D D Jones; H L Currey
Journal: Ann Rheum Dis Date: 1986-01 Impact factor: 19.103